CANADIAN DAILY STOCK REPORT
Corporate Wire Date: 13 September 2017 20:16 EDT
ORIGINAL ANNOUNCEMENT [Text]
TORONTO, ONTARIO--(Marketwired - Sept. 13, 2017) - Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation.
Microbix' revenues are derived principally from the sales of its antigens for
RelSci News & Alerts gets you: